Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Royston

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1995
Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinomaD L Shawler, O Dorigo, R A Gjerset, et al.
Cellular Immunology|August 1, 1988
Unique subset of thymic epithelial cells defined by the expression of a novel neuroendocrine antigenR E Sobol, D Burton, M T Schaeffer, et al.
Journal of the National Cancer Institute|September 1, 1987
Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibodyR E Sobol, R W Astarita, C Hofeditz, et al.
Journal of Biological Response Modifiers|January 1, 1983
In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1R O Dillman, J C Beauregard, M I Zavanelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease statesR I Fox, M Hueniken, S Fong, et al.
Cancer|October 15, 1985
Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphomaR E Sobol, R O Dillman, H Collins, et al.
Human Gene Therapy|May 1, 1995
Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunityH Fakhrai, D L Shawler, R Gjerset, et al.
Cancer Research|June 1, 1987
Establishment of a human B-cell tumor in athymic miceJ E Leonard, D E Johnson, R B Felsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983
Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlationsR O Dillman, J C Beauregard, J W Lea, et al.
The New England Journal of Medicine|September 28, 1989
Shared idiotypes expressed by human B-cell lymphomasR A Miller, S Hart, M Samoszuk, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1995
Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinomaD L Shawler, O Dorigo, R A Gjerset, et al.
Cellular Immunology|August 1, 1988
Unique subset of thymic epithelial cells defined by the expression of a novel neuroendocrine antigenR E Sobol, D Burton, M T Schaeffer, et al.
Journal of the National Cancer Institute|September 1, 1987
Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibodyR E Sobol, R W Astarita, C Hofeditz, et al.
Journal of Biological Response Modifiers|January 1, 1983
In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1R O Dillman, J C Beauregard, M I Zavanelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1983
A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease statesR I Fox, M Hueniken, S Fong, et al.
Cancer|October 15, 1985
Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphomaR E Sobol, R O Dillman, H Collins, et al.
Human Gene Therapy|May 1, 1995
Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunityH Fakhrai, D L Shawler, R Gjerset, et al.
Cancer Research|June 1, 1987
Establishment of a human B-cell tumor in athymic miceJ E Leonard, D E Johnson, R B Felsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1983
Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlationsR O Dillman, J C Beauregard, J W Lea, et al.
The New England Journal of Medicine|September 28, 1989
Shared idiotypes expressed by human B-cell lymphomasR A Miller, S Hart, M Samoszuk, et al.
Pageof 8